Skip to content

Effect of Repeated Remote Ischemic Preconditioning on Conditioning in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass

Effect of Repeated Remote Ischemic Preconditioning on Conditioning in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103370
Enrollment
Unknown
Registered
2025-05-28
Start date
2022-01-14
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Remote ischemic preconditioning group:One day before surgery, a blood pressure cuff was wrapped around the upper arm and inflated to 200 mm Hg. This was maintained for 5 minutes, followed by deflation
Repeated remote ischemic preconditioning group:Remote ischemic preconditioning (RIPC) was performed on the day before surgery and the day of surgery, using the same method as the traditional RIPC grou
Control group:No intervention, patients are directly taken to the operating room for treatment.

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1 .Age >= 18 years; 2. Selected for surgical procedures under cardiopulmonary bypass (CPB) 3.Preoperative levels of cTnI and CK-MB are normal. 4. Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Severe neurological dysfunction or concurrent tumors; 2. Oral administration of sulfonylurea hypoglycemic drugs within the past three months; 3. Active rheumatic diseases, recent infections, major trauma, major surgery, or other diseases affecting systemic inflammatory response; 4. Peripheral vascular diseases or limb disabilities that are contraindications for remote ischemic preconditioning (RIPC).

Design outcomes

Primary

MeasureTime frame
Creatine kinase isoenzyme, CK-MB;High-sensitivity troponin I, Hs-cTnI;NT-proBNP;Creatinine;Interleukin-6, IL-6;High-sensitivity C-reactive protein, hs-CRP;

Secondary

MeasureTime frame
In-hospital major adverse cardiovascular events, MACEs;Electrocardiogram changes;Vital signs changes;

Countries

China

Contacts

Public ContactHong Zhu

Xuzhou Medical University Affiliated Hospital

hongzhumao@sohu.com+86 138 0521 9897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026